Baudax Bio, Inc. announced that it has entered into a share purchase agreement for the gross proceeds of $50 million on August 23, 2023. The transaction will include participation from new investor, Alumni Capital LP.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0043 USD | +65.38% |
|
-42.67% | -80.45% |
Jun. 17 | First Motion for Exclusivity Period Extension Filed by Baudax Bio, Inc. | CI |
Feb. 22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
1st Jan change | Capi. | |
---|---|---|
-80.45% | 226K | |
+17.09% | 44.63B | |
+43.12% | 40.46B | |
-9.70% | 38.07B | |
+33.28% | 32.27B | |
-8.98% | 27.3B | |
+13.37% | 26.53B | |
+44.11% | 14.06B | |
+32.33% | 12.54B | |
-7.26% | 11.28B |
- Stock Market
- Equities
- BXRXQ Stock
- News Baudax Bio, Inc.
- Baudax Bio, Inc. announced that it expects to receive $50 million in funding from Alumni Capital LP